AJG Quote, Financials, Valuation and Earnings

CorVel has a net margin of 9.51% compared to Arthur J. Gallagher &'s net margin of 10.43%. Arthur J. Gallagher &'s return on equity of 11.06% beat CorVel's return on equity of 33.19%.

Arthur J. Gallagher & has a consensus price target of $332.81, signalling downside risk potential of -0.36%. On the other hand CorVel has an analysts' consensus of -- which suggests that it could fall by --. Given that Arthur J. Gallagher & has higher upside potential than CorVel, analysts believe Arthur J. Gallagher & is more attractive than CorVel.

Arthur J. Gallagher & has a beta of 0.641, which suggesting that the stock is 35.887% less volatile than S&P 500. In comparison CorVel has a beta of 0.939, suggesting its less volatile than the S&P 500 by 6.112%.

Arthur J. Gallagher & has a quarterly dividend of $0.65 per share corresponding to a yield of 0.73%. CorVel offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Arthur J. Gallagher & pays 35.92% of its earnings as a dividend. CorVel pays out -- of its earnings as a dividend. Arthur J. Gallagher &'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Arthur J. Gallagher & quarterly revenues are $2.7B, which are larger than CorVel quarterly revenues of $228M. Arthur J. Gallagher &'s net income of $258.3M is higher than CorVel's net income of $23.8M. Notably, Arthur J. Gallagher &'s price-to-earnings ratio is 51.23x while CorVel's PE ratio is 68.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Arthur J. Gallagher & is 6.50x versus 6.91x for CorVel. Usually stocks with elevated PS ratios are considered overvalued.

eHealth has a net margin of 9.51% compared to Arthur J. Gallagher &'s net margin of 30.93%. Arthur J. Gallagher &'s return on equity of 11.06% beat eHealth's return on equity of 1.6%.

Arthur J. Gallagher & has a consensus price target of $332.81, signalling downside risk potential of -0.36%. On the other hand eHealth has an analysts' consensus of $10.63 which suggests that it could grow by 78.27%. Given that eHealth has higher upside potential than Arthur J. Gallagher &, analysts believe eHealth is more attractive than Arthur J. Gallagher &.

Arthur J. Gallagher & has a beta of 0.641, which suggesting that the stock is 35.887% less volatile than S&P 500. In comparison eHealth has a beta of 0.810, suggesting its less volatile than the S&P 500 by 19.024%.

Arthur J. Gallagher & has a quarterly dividend of $0.65 per share corresponding to a yield of 0.73%. eHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Arthur J. Gallagher & pays 35.92% of its earnings as a dividend. eHealth pays out 55.3% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Arthur J. Gallagher & quarterly revenues are $2.7B, which are larger than eHealth quarterly revenues of $315.2M. Arthur J. Gallagher &'s net income of $258.3M is higher than eHealth's net income of $97.5M. Notably, Arthur J. Gallagher &'s price-to-earnings ratio is 51.23x while eHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Arthur J. Gallagher & is 6.50x versus 0.33x for eHealth. Usually stocks with elevated PS ratios are considered overvalued.

Kingstone Companies has a net margin of 9.51% compared to Arthur J. Gallagher &'s net margin of 12.92%. Arthur J. Gallagher &'s return on equity of 11.06% beat Kingstone Companies's return on equity of 38.66%.

Arthur J. Gallagher & has a consensus price target of $332.81, signalling downside risk potential of -0.36%. On the other hand Kingstone Companies has an analysts' consensus of $19.00 which suggests that it could grow by 15.08%. Given that Kingstone Companies has higher upside potential than Arthur J. Gallagher &, analysts believe Kingstone Companies is more attractive than Arthur J. Gallagher &.

Arthur J. Gallagher & has a beta of 0.641, which suggesting that the stock is 35.887% less volatile than S&P 500. In comparison Kingstone Companies has a beta of 0.481, suggesting its less volatile than the S&P 500 by 51.89%.

Arthur J. Gallagher & has a quarterly dividend of $0.65 per share corresponding to a yield of 0.73%. Kingstone Companies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Arthur J. Gallagher & pays 35.92% of its earnings as a dividend. Kingstone Companies pays out -- of its earnings as a dividend. Arthur J. Gallagher &'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Arthur J. Gallagher & quarterly revenues are $2.7B, which are larger than Kingstone Companies quarterly revenues of $42.1M. Arthur J. Gallagher &'s net income of $258.3M is higher than Kingstone Companies's net income of $5.4M. Notably, Arthur J. Gallagher &'s price-to-earnings ratio is 51.23x while Kingstone Companies's PE ratio is 11.47x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Arthur J. Gallagher & is 6.50x versus 1.32x for Kingstone Companies. Usually stocks with elevated PS ratios are considered overvalued.

Marsh & McLennan Companies has a net margin of 9.51% compared to Arthur J. Gallagher &'s net margin of 12.99%. Arthur J. Gallagher &'s return on equity of 11.06% beat Marsh & McLennan Companies's return on equity of 30.77%.

Arthur J. Gallagher & has a consensus price target of $332.81, signalling downside risk potential of -0.36%. On the other hand Marsh & McLennan Companies has an analysts' consensus of $237.30 which suggests that it could grow by 3.73%. Given that Marsh & McLennan Companies has higher upside potential than Arthur J. Gallagher &, analysts believe Marsh & McLennan Companies is more attractive than Arthur J. Gallagher &.

Arthur J. Gallagher & has a beta of 0.641, which suggesting that the stock is 35.887% less volatile than S&P 500. In comparison Marsh & McLennan Companies has a beta of 0.849, suggesting its less volatile than the S&P 500 by 15.053%.

Arthur J. Gallagher & has a quarterly dividend of $0.65 per share corresponding to a yield of 0.73%. Marsh & McLennan Companies offers a yield of 1.43% to investors and pays a quarterly dividend of $0.82 per share. Arthur J. Gallagher & pays 35.92% of its earnings as a dividend. Marsh & McLennan Companies pays out 37.27% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Arthur J. Gallagher & quarterly revenues are $2.7B, which are smaller than Marsh & McLennan Companies quarterly revenues of $6.1B. Arthur J. Gallagher &'s net income of $258.3M is lower than Marsh & McLennan Companies's net income of $788M. Notably, Arthur J. Gallagher &'s price-to-earnings ratio is 51.23x while Marsh & McLennan Companies's PE ratio is 27.93x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Arthur J. Gallagher & is 6.50x versus 4.64x for Marsh & McLennan Companies. Usually stocks with elevated PS ratios are considered overvalued.